Anonymous 04/06/2021 (Tue) 03:16:22 Id: ffa799 No.7446 del
Moderna is a super hot private biotech company that has raised $1.9 billion. That includes deals it has made with big companies likeMerck, Alexion and AstraZeneca,and investor cash most recently raised at a valuation of $5 billion. Led by Stéphane Bancel, Moderna is developing a new class of mRNA drugs aiming to turn human bodies into drug factories by directing cells to produce therapeutic proteins.

But getting the mRNA safely into the body’s cells is tricky. Acuitas, which is based in its CEO’s Vanouver home, sublicensed one delivery system to Moderna that wraps the mRNA in balls of fat. That delivery system belongs to Arbutus and last year it terminated Aquitas’ license to the technology. Acuitas turned around and sued Arbutus in Vancouver to preserve its rights to the techonology. Acuitas originally got the license as a result of a separate legal dispute and richly-funded Moderna tapped Acuitas for the delivery system instead of its actual owner, Arbutus.